FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2202038173> ?p ?o ?g. }

• W2202038173 endingPage "310" @default.
• W2202038173 startingPage "303" @default.
• W2202038173 abstract "Objective Catheter-directed interventions (CDIs) are increasingly performed for acute pulmonary embolism (PE) as they are presumed to provide similar therapeutic benefits to systemic thrombolysis while decreasing the dose of thrombolytic required and the associated risks. This study aimed to identify factors associated with CDI failure and to describe anticipated complications. Methods Consecutive patients who underwent CDI for massive or submassive PE between 2009 and 2015 were identified; outcomes and complications were retrospectively collected. CDI clinical failure was defined as major bleeding, perioperative stroke or other major adverse procedure-related event, decompensation for submassive or persistent shock for massive PE, need for surgical thromboembolectomy, or in-hospital death. Univariate analysis was used to study the factors associated with CDI failure. Results There were 102 patients who received a CDI during the study period (36 standard catheter thrombolysis, 60 ultrasound assisted, 6 other; age, 59.2 ± 15.9 years; male, 50 [49.0%]; massive PE, 14 [13.7%]). Five patients (4.9%) had a major contraindication and 15 patients (14.7%) had a minor contraindication to systemic thrombolysis. The mean alteplase dose was 28.2 ± 18.8 mg (range, 0-123 mg; three patients had already received systemic lysis). CDI failure occurred in 15 patients (14.7%; 7 in massive PE, 8 in submassive PE). Of these patients, seven had major bleeding events, whereas eight patients decompensated. Ten (9.8%) patients had minor bleeding events (four access related). Factors associated with CDI failure and major bleeding included massive PE, age ≥70 years, and major contraindication to thrombolytics. Both failures and bleeding events were independent of lysis dose and CDI technique. Conclusions CDIs for acute PE are not risk-free procedures, and their use should be individualized on the basis of a risk-benefit ratio. Particularly for patients with major contraindications to systemic thrombolytics, CDIs should be used selectively. Lytic dose, within the low-volume range administered in CDI, and type of CDI seem to have no impact on adverse events." @default.
• W2202038173 created "2016-06-24" @default.
• W2202038173 creator A5001794232 @default.
• W2202038173 creator A5015166940 @default.
• W2202038173 creator A5021911875 @default.
• W2202038173 creator A5039147795 @default.
• W2202038173 creator A5047489604 @default.
• W2202038173 creator A5070822782 @default.
• W2202038173 creator A5072920508 @default.
• W2202038173 date "2017-05-01" @default.
• W2202038173 modified "2023-09-28" @default.
• W2202038173 title "Predictors of failure and complications of catheter-directed interventions for pulmonary embolism" @default.
• W2202038173 cites W1141106418 @default.
• W2202038173 cites W1596397105 @default.
• W2202038173 cites W1978243757 @default.
• W2202038173 cites W1993443958 @default.
• W2202038173 cites W2002821499 @default.
• W2202038173 cites W2011611174 @default.
• W2202038173 cites W2033150840 @default.
• W2202038173 cites W2042418657 @default.
• W2202038173 cites W2075776825 @default.
• W2202038173 cites W2083658263 @default.
• W2202038173 cites W2102535207 @default.
• W2202038173 cites W2107941853 @default.
• W2202038173 cites W2108490506 @default.
• W2202038173 cites W2120203545 @default.
• W2202038173 cites W2124971489 @default.
• W2202038173 cites W2129593751 @default.
• W2202038173 cites W2133170459 @default.
• W2202038173 cites W2145404820 @default.
• W2202038173 cites W2146066346 @default.
• W2202038173 cites W2147615829 @default.
• W2202038173 cites W2150122170 @default.
• W2202038173 cites W2156917466 @default.
• W2202038173 cites W2159007980 @default.
• W2202038173 cites W2165786903 @default.
• W2202038173 cites W2204732044 @default.
• W2202038173 cites W2224057980 @default.
• W2202038173 cites W2225937646 @default.
• W2202038173 cites W2238383377 @default.
• W2202038173 cites W2325152935 @default.
• W2202038173 cites W2344523019 @default.
• W2202038173 cites W2557499226 @default.
• W2202038173 cites W4253691854 @default.
• W2202038173 doi "https://doi.org/10.1016/j.jvsv.2016.12.013" @default.
• W2202038173 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6394221" @default.
• W2202038173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28411694" @default.
• W2202038173 hasPublicationYear "2017" @default.
• W2202038173 type Work @default.
• W2202038173 sameAs 2202038173 @default.
• W2202038173 citedByCount "10" @default.
• W2202038173 countsByYear W22020381732018 @default.
• W2202038173 countsByYear W22020381732019 @default.
• W2202038173 countsByYear W22020381732020 @default.
• W2202038173 countsByYear W22020381732021 @default.
• W2202038173 countsByYear W22020381732022 @default.
• W2202038173 crossrefType "journal-article" @default.
• W2202038173 hasAuthorship W2202038173A5001794232 @default.
• W2202038173 hasAuthorship W2202038173A5015166940 @default.
• W2202038173 hasAuthorship W2202038173A5021911875 @default.
• W2202038173 hasAuthorship W2202038173A5039147795 @default.
• W2202038173 hasAuthorship W2202038173A5047489604 @default.
• W2202038173 hasAuthorship W2202038173A5070822782 @default.
• W2202038173 hasAuthorship W2202038173A5072920508 @default.
• W2202038173 hasBestOaLocation W22020381732 @default.
• W2202038173 hasConcept C126322002 @default.
• W2202038173 hasConcept C127413603 @default.
• W2202038173 hasConcept C141071460 @default.
• W2202038173 hasConcept C142724271 @default.
• W2202038173 hasConcept C197934379 @default.
• W2202038173 hasConcept C204787440 @default.
• W2202038173 hasConcept C2776265017 @default.
• W2202038173 hasConcept C2776494729 @default.
• W2202038173 hasConcept C2778721985 @default.
• W2202038173 hasConcept C2779581417 @default.
• W2202038173 hasConcept C2780645631 @default.
• W2202038173 hasConcept C31174226 @default.
• W2202038173 hasConcept C500558357 @default.
• W2202038173 hasConcept C71924100 @default.
• W2202038173 hasConcept C78519656 @default.
• W2202038173 hasConceptScore W2202038173C126322002 @default.
• W2202038173 hasConceptScore W2202038173C127413603 @default.
• W2202038173 hasConceptScore W2202038173C141071460 @default.
• W2202038173 hasConceptScore W2202038173C142724271 @default.
• W2202038173 hasConceptScore W2202038173C197934379 @default.
• W2202038173 hasConceptScore W2202038173C204787440 @default.
• W2202038173 hasConceptScore W2202038173C2776265017 @default.
• W2202038173 hasConceptScore W2202038173C2776494729 @default.
• W2202038173 hasConceptScore W2202038173C2778721985 @default.
• W2202038173 hasConceptScore W2202038173C2779581417 @default.
• W2202038173 hasConceptScore W2202038173C2780645631 @default.
• W2202038173 hasConceptScore W2202038173C31174226 @default.
• W2202038173 hasConceptScore W2202038173C500558357 @default.
• W2202038173 hasConceptScore W2202038173C71924100 @default.
• W2202038173 hasConceptScore W2202038173C78519656 @default.
• W2202038173 hasIssue "3" @default.
• W2202038173 hasLocation W22020381731 @default.
• W2202038173 hasLocation W22020381732 @default.

• next